Cuba Offers Vaccine Against Lung Cancer

Jul 01, 2008 11:32

30.06.2008

Cuban scientists have recently revealed a lung cancer vaccine which they say is the first in the world of its kind and extends the lives of victims by up to five months or even longer. Research on the vaccine, called Cimavax EGF, began in 1992, with the first clinical tests done in 1995. Cimavas EGF is the first registered vaccine in the world designed to battlelung cancer.

Cimavas EGF, based on two proteins, triggers an immune response from the victim's body and has absolutely no side effects, as most anti-cancer therapy does. The vaccine only attacks cancer cells. The vaccine is meant to serve as a compliment to rather than a replacement for conventional methods such as chemotherapy and radiation. The vaccine also improves patients’ breathing and decreases their pain.

The vaccine currently is available in Cuba to anyone who needs it, and will be widely commercialized in Latin America after first being introduced in Peru. Advanced tests are currently underway.

Latin American School of Medical Sciences

--MORE--

cancer, cuba

Previous post Next post
Up